Quick Answer
ABEONA THERAPEUTICS INC. reported Operating Income Loss of -$89.45 million for the year ending 2025.
- ABEONA THERAPEUTICS INC. showed a decrease of -39.3% in Operating Income Loss from 2024 to 2025.
- This data is from ABEONA THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ABEONA THERAPEUTICS INC.'s Operating Income Loss has declined by 1,053.1%.
- Historical annual values: Fiscal year 2025: -$89.45 million | Fiscal year 2024: -$64.21 million | Fiscal year 2023: -$47.14 million | Fiscal year 2022: -$50.92 million | Fiscal year 2021: -$89.84 million | Fiscal year 2020: -$81.42 million | Fiscal year 2019: -$77.09 million | Fiscal year 2018: -$58.17 million | Fiscal year 2017: -$27.84 million | Fiscal year 2016: -$23.88 million | Fiscal year 2015: -$18.55 million | Fiscal year 2014: -$3.13 million | Fiscal year 2013: -$3.80 million | Fiscal year 2012: -$4.32 million | Fiscal year 2011: -$7.88 million | Fiscal year 2010: -$7.76 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: